Trial Profile
A retrospective observational study of switching to emtricitabine/tenofovir/rilpivirine from anti-retroviral treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2015
Price :
$35
*
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 21 Sep 2015 New trial record